ARTV·04317A107·US·equity·Healthcare - Biotechnology-13D/G
ARTV (ARTIVA BIOTHERAPEUTICS INC) is held by 25 institutional investors as of Q4 2025. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($42.3M), FRANKLIN RESOURCES INC ($2.2M), VANGUARD GROUP INC ($1.1M). Net institutional sentiment: Bearish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer